Veraxa Biotech AG

Contributing Author

Recent Articles by Veraxa Biotech AG

Jul-29	VERAXA Biotech Strengthens Patent Portfolio to Protect Core Technology Platforms and Product Candidates VRXA GlobeNewswire
Jul-27	VERAXA Biotech Announces Advancement of Novel Bispecific Antibody Drug Conjugate Program VXA-222 from Joint Discovery Collaboration with OmniAb VRXA +11.67% GlobeNewswire
Jul-24	VERAXA Biotech Shareholders Approve All Proposals at Extraordinary General Meeting, Strengthening Strategic Flexibility for Future Growth VRXA GlobeNewswire
Jul-23	VERAXA Biotech Appoints Christoph Erkel as Chief Scientific Officer to Advance BiTAC Technology Platforms and Portfolio VRXA -9.27% GlobeNewswire
Jul-20	VERAXA Biotech Announces Regulatory Progress with its BiTAC-TCE Development Plan VRXA GlobeNewswire
Jul-13	VERAXA Biotech to Launch AI-enabled Drug Discovery Collaboration with Ardigen to Support Growing BiTAC Pipeline VRXA GlobeNewswire